FDA approves belzutifan for cancers associated with von Hippel-Lindau disease | FDA January 29, 20240CommentsRead MoreRead More
Identification of Smurf2 as a HIF-1α degrading E3 ubiquitin ligase | Oncotarget January 29, 20240CommentsRead MoreRead More
Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease | NEJM January 29, 20240CommentsRead MoreRead More
Dr. Wafik El-Deiry comments on the future of cancer treatment January 17, 20240CommentsWatch NowRead More